Persistence rate of anti-osteoporosis drug treatment in hip fracture patient Osteoporosis, Hip fracture
Conditions
Interventions
Patient who initiate the treatment after received the prescription and persistent to medication.,Patient who did not initiate the treatment after received the prescription.,The patient whom had alrea
Other,Other,Other
Persistence,Primary Non-persistence,Secondary Non-persistence
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Previous osteoporotic hip fracture patient whom admitted and operated in Siriraj hospital 2. Age 50 years old or more 3. At least 1 year follow-up period
Exclusion criteria
Exclusion criteria: 1. Pathological hip fracture 2. Atypical femoral fracture 3. High energy injury 4. Inability to communicate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Persistence rate 1 year Prescription of anti-osteoporosis agent | — |
Secondary
| Measure | Time frame |
|---|---|
| Reason of non-persistence 1 year Reason of discontinuation of anti-osteoporosis agent | — |
Countries
Thailand
Contacts
Public ContactEkasame Vanitcharoenkul
Faculty of Medicine Siriraj Hospital
Outcome results
None listed